Kronos Bio, Inc. (KRON)
NASDAQ: KRON · Real-Time Price · USD
0.948
+0.028 (2.99%)
Sep 19, 2024, 4:00 PM EDT - Market closed
Kronos Bio Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Kronos Bio stock have an average target of 4.13, with a low estimate of 2.25 and a high estimate of 6.00. The average target predicts an increase of 335.84% from the current stock price of 0.95.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 19, 2024.
Analyst Ratings
The average analyst rating for Kronos Bio stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '24 | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $2.25 | Strong Buy | Reiterates | $2.25 | +137.44% | Aug 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $2.25 | Strong Buy | Reiterates | $2.25 | +137.44% | Aug 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $2.5 → $2.25 | Strong Buy | Maintains | $2.5 → $2.25 | +137.44% | May 3, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $7 → $6 | Buy | Maintains | $7 → $6 | +533.18% | Dec 19, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $2.5 | Strong Buy | Maintains | $9 → $2.5 | +163.82% | Dec 19, 2023 |
Financial Forecast
Revenue This Year
9.60M
from 6.29M
Increased by 52.62%
Revenue Next Year
3.52M
from 9.60M
Decreased by -63.30%
EPS This Year
-1.38
from -1.95
EPS Next Year
-1.41
from -1.38
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 10.7M | 5.3M | n/a | ||
| Avg | 9.6M | 3.5M | n/a | ||
| Low | 7.1M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 70.5% | -45.3% | - | ||
| Avg | 52.6% | -63.3% | - | ||
| Low | 12.5% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.25 | -1.11 | -1.22 |
| Avg | -1.38 | -1.41 | -1.66 |
| Low | -1.42 | -1.71 | -2.06 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.